Latest News & Features
Europe
Teva Pharmaceutical Industries has claimed victory in a patent revocation action brought by generic drug maker Mylan in the Hague over its blockbuster Copaxone drug, used in the treatment of multiple sclerosis. 4 October 2013
article
Swedish law firm Vinge has hired IP specialist Ulf Dahlgren to its Stockholm office from rivals Lindahl, following Håkan Borgenhäll’s move from the same firm in April. 3 October 2013
Americas
Mylan Inc will be forced to divest injectable generic drugs before it can complete a proposed $1.85 billion acquisition of Agila Specialities Global Pte Ltd and Agila Specialties Pvt Ltd after the FTC applied conditions to the deal. 2 October 2013
Americas
US law firm Baker Botts has expanded its Houston office with the addition of IP litigator Nicolas Barzoukas. 1 October 2013
Americas
India’s drug patent policy has been slammed by US companies who are insisting that action be taken in order to improve trade relations. 30 September 2013
Americas
A federal judge has denied AstraZeneca’s motions to dismiss claims challenging its pay-for-delay deals with three generic pharmaceutical companies in connection to heartburn drug Nexium. 27 September 2013
Americas
A US company which provides secure personal medical records online has filed a patent infringement case against a rival health-care company. 26 September 2013
Big Pharma
The government in South Africa is considering changing its national policy on IP, a move that could have far reaching effects for its patents system. 26 September 2013
Asia
A Japanese research institution has collaborated with three Indian organisations to launch two new virtual centres for scientists and students. 25 September 2013
Americas
The US District Court for the District of New Jersey has found in favour of Teva Pharmaceutical Industries Ltd in its patent infringement case with Mylan over Parkinson’s disease drug Azilect. 25 September 2013